Mid-term outcomes of patients with Lotus and Evolut transcatheter valves

INTRODUCTION: Long-term data on the Lotus(®) (Boston Scientific, USA) valve are lacking. AIM: To evaluate mid-term outcomes of aortic stenosis patients treated with either Lotus or Evolut R(®) valves (Medtronic, USA). MATERIAL AND METHODS: Our study sample comprised 190 patients (71 Lotus and 119 Ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Hájek, Petr, Polaková, Eva, Adlová, Radka, Horváth, Martin, Hansvenclová, Eva, Pecková, Monika, Veselka, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421513/
https://www.ncbi.nlm.nih.gov/pubmed/36051828
http://dx.doi.org/10.5114/aic.2022.118531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421513/
https://www.ncbi.nlm.nih.gov/pubmed/36051828
http://dx.doi.org/10.5114/aic.2022.118531

Ejemplares similares